Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board
Ground breaking medical innovation, better patient outcomes, strong financial returns.
Brandon has been effective in raising successive funds that collectively cover the spectrum of life science venture investing. We also have a co-investment arrangement with our investors, providing significant capacity to support our advancing portfolio companies.
active portfolio companies
Investors and Venture Partners spanning Australia, New Zealand, United States and the United Kingdom
